Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
As Arizona public schools continue to navigate declining enrollment and ongoing budget constraints, a bill introduced this legislative session could limit how public school libraries use their funds ...
Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...
In order to improve care for people with multiple sclerosis (MS), we need to understand more about their disease. The way we measure the impact of MS on daily life has remained relatively unchanged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results